Evidence map›Paper›PMID 39104886›Full record

ArticleFrontiers in public health2024

What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate.

Francesca Pistollato, Gregor Burkhart, Pierre Deceuninck, Camilla Bernasconi, Sergio Di Virgilio, Luca Emili, Anne-Charlotte Fauvel, Luisa Ferreira Bastos, Annalisa Gastaldello, Chiara Gerardi and 13 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Francesca PistollatoResearch and Toxicology, Humane Society International, Brussels, Belgium.
Gregor BurkhartEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
Pierre DeceuninckEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Camilla BernasconiEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Sergio Di VirgilioEuropean Commission, Research and Innovation (R&I), Brussels, Belgium.
Luca EmiliInSilicoTrials Technologies, Milan, Italy.
Anne-Charlotte FauvelEuropean Infrastructure for Translational Medicine, Amsterdam, Netherlands.
Luisa Ferreira BastosEurogroup for Animals, Brussels, Belgium.
Annalisa GastaldelloEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Chiara GerardiCenter for Health Regulatory Policies, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy.
Jens K HabermannBBMRI-ERIC, Biobanking and Biomolecular Resources Research Infrastructure Consortium, Graz, Austria.
Ioan HanesEuropean Lifestyle Medicine Organization, Geneva, Switzerland.
Christina KyriakopoulouEuropean Commission, Research and Innovation (R&I), Brussels, Belgium.
Uma LankaResearch and Toxicology, Humane Society International, London, United Kingdom.
Paolo LauriolaInternational Society of Doctors for the Environment, Modena, Italy.
Hugh LavertyInnovative Health Initiative, Brussels, Belgium.
Benoit G C MaisonneuveNETRI - Digitizing Human Biology, Lyon, France.
Milena MennecozziEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Francesco PappalardoDepartment of Drug and Health Sciences, University of Catania, Catania, Italy.
Roberta PastorinoSection of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Vilma RadvilaiteEuropean Innovation Council, Brussels, Belgium.
Erwin L RoggenToxGenSolutions and 3Rs Management & Consulting ApS, Maastricht, Netherlands.
Helder ConstantinoResearch and Toxicology, Humane Society International, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade, significant European calls for research proposals have supported translational collaborative research on non-communicable and infectious diseases within the biomedical life sciences by bringing together interdisciplinary and multinational consortia. This research has advanced our understanding of disease pathophysiology, marking considerable scientific progress. Yet, it is crucial to retrospectively evaluate these efforts' societal impact. Research proposals should be thoughtfully designed to ensure that the research findings can be effectively translated into actionable policies. In addition, the choice of scientific methods plays a pivotal role in shaping the societal impact of research discoveries. Understanding the factors responsible for current unmet public health issues and medical needs is crucial for crafting innovative strategies for research policy interventions. A multistakeholder survey and a roundtable helped identify potential needs for consideration in the EU research and policy agenda. Based on survey findings, mental health disorders, metabolic syndrome, cancer, antimicrobial resistance, environmental pollution, and cardiovascular diseases were considered the public health challenges deserving prioritisation. In addition, early diagnosis, primary prevention, the impact of environmental pollution on disease onset and personalised medicine approaches were the most selected unmet medical needs. Survey findings enabled the formulation of some research-policies interventions (RPIs), which were further discussed during a multistakeholder online roundtable. The discussion underscored recent EU-level activities aligned with the survey-derived RPIs and facilitated an exchange of perspectives on public health and biomedical research topics ripe for interdisciplinary collaboration and warranting attention within the EU's research and policy agenda. Actionable recommendations aimed at facilitating the translation of knowledge into transformative, science-based policies are also provided.

Indexed as

European UnionPublic HealthHealth PolicyHealth Services Needs and DemandHumansStakeholder ParticipationSurveys and Questionnairesbiomedical researchfundingpatient-centric researchpolicypublic healthresearch innovative methodologiessocietal impacttranslatability

Identifiers

PMID39104886
PMCPMC11298480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.